Nature Communications (Jul 2019)

Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response

  • Krist Helen Antunes,
  • José Luís Fachi,
  • Rosemeire de Paula,
  • Emanuelle Fraga da Silva,
  • Laís Passariello Pral,
  • Adara Áurea dos Santos,
  • Greicy Brisa Malaquias Dias,
  • José Eduardo Vargas,
  • Renato Puga,
  • Fabiana Quoos Mayer,
  • Fábio Maito,
  • Carlos R. Zárate-Bladés,
  • Nadim J. Ajami,
  • Marcella Ramos Sant’Ana,
  • Thamiris Candreva,
  • Hosana Gomes Rodrigues,
  • Marcio Schmiele,
  • Maria Teresa Pedrosa Silva Clerici,
  • José Luiz Proença-Modena,
  • Angélica Thomas Vieira,
  • Charles R. Mackay,
  • Daniel Mansur,
  • Mauricio T. Caballero,
  • Jacqui Marzec,
  • Jianying Li,
  • Xuting Wang,
  • Douglas Bell,
  • Fernando P. Polack,
  • Steven R. Kleeberger,
  • Renato T. Stein,
  • Marco Aurélio Ramirez Vinolo,
  • Ana Paula Duarte de Souza

DOI
https://doi.org/10.1038/s41467-019-11152-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 17

Abstract

Read online

Dietary fibers and SCFAs can exert a protective effect against respiratory syncytial virus (RSV). Here, the authors report that microbiota-derived acetate protects mice against RSV infection via GPR43- mediated type 1 interferon response induction in the lungs.